Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 71 publications
Retraction Note: Overexpression of HMGA1 promotes anoikis resistance and constitutive Akt activation in pancreatic adenocarcinoma cells.
Journal: British journal of cancer
Published: April 30, 2025
Editor's Note: HMGA1 Is a Molecular Determinant of Chemoresistance to Gemcitabine in Pancreatic Adenocarcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 05, 2025
Editor's Note: RNA Interference Demonstrates a Novel Role for Integrin-Linked Kinase as a Determinant of Pancreatic Adenocarcinoma Cell Gemcitabine Chemoresistance.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 05, 2025
Retraction: Prostaglandin E2 Enhances Pancreatic Cancer Invasiveness through an Ets-1-Dependent Induction of Matrix Metalloproteinase-2.
Journal: Cancer research
Published: February 25, 2025
Editor's Note: A Novel Role for Carcinoembryonic Antigen-Related Cell Adhesion Molecule 6 as a Determinant of Gemcitabine Chemoresistance in Pancreatic Adenocarcinoma Cells.
Journal: Cancer research
Published: February 25, 2025
Perspectives of Surgical Research Residents on Improving Their Reentry Into Clinical Training.
Journal: Journal of surgical education
Published: May 03, 2024
Standing with our Veterans: Improving access to Veterans Affairs healthcare for their families.
Journal: American journal of surgery
Published: February 27, 2024
Editorial Expression of Concern: Overexpression of CEACAM6 promotes insulin-like growth factor I-induced pancreatic adenocarcinoma cellular invasiveness.
Journal: Oncogene
Published: July 19, 2023
Withdrawal: CEACAM6 cross-linking induces caveolin-1-dependent, Src-mediated focal adhesion kinase phosphorylation in BxPC3 pancreatic adenocarcinoma cells.
Journal: The Journal of biological chemistry
Published: July 10, 2023
Retraction Note: RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine.
Journal: Oncogene
Published: February 16, 2023
Retraction notice to Glucose transporter-1 gene expression is associated with pancreatic cancer invasiveness and MMP-2 activity [Surgery -September 2004, Pages 548-556].
Journal: Surgery
Published: February 13, 2023
Last Updated: 09/26/2026